Phase
Condition
Obesity
Hypertriglyceridemia
Treatment
Placebo
Probiotic
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men and women aged ≥ 18 years.
Body Mass Index (BMI) between 25.0 and 34.9 (overweight or obesity type I).
Commitment to maintaining a lifestyle, including diet and sports habits, constantthroughout the study.
Signing of informed consent.
Exclusion
Exclusion Criteria:
Subjects with diabetes (type I or II), hypothyroidism or other diseases that maypromote weight gain.
Presence of other serious pathologies, including cancer or autoimmune diseases, orany other that, at the medical discretion of the investigator, may influence theresults of the study.
Subjects who have participated in a weight loss program or who have substantiallymodified their lifestyle habits (diet, physical exercise) during the previous 3months.
Treatment with antibiotics in the previous 4 weeks.
Consumption of products or drugs intended for weight loss or satiety control, orthat may influence weight in the previous 4 weeks.
Consumption of products containing probiotics in the previous 2 months.
Contraindication to taking the product under investigation, or allergy orintolerance to any of its ingredients.
In the case of women: pregnancy or breastfeeding, or plans to become pregnant duringthe course of the study.
Study Design
Connect with a study center
MiBioPath Research Group (UCAM)
Murcia,
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.